Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Akumin	Oncimmune	Yourgene Health	Biodesix	Profound Medical
Symbol	TSE:AKU	LON:ONC	LON:YGEN	NASDAQ:BDSX	TSE:PRN
Price Information
Current Price	C$3.96	GBX 210	GBX 14.87	$18.24	C$23.76
52 Week Range	Buy	N/A	N/A	Buy	Strong Buy
MarketRank™
Overall Score	0.7	0.4	0.7	1.6	0.0
Analysis Score	1.3	0.0	0.0	3.5	0.0
Community Score	2.4	2.1	1.8	3.8	0.0
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	0.0	1.7	0.0	0.0
Earnings & Valuation Score	0.0	0.0	0.0	0.6	0.0
Analyst Ratings
Consensus Recommendation	Buy	N/A	N/A	Buy	Strong Buy
Consensus Price Target	C$4.25	N/A	N/A	$26.00	C$43.00
% Upside from Price Target	7.32% upside	N/A	N/A	42.54% upside	80.98% upside
Trade Information
Market Cap	C$274.09 million	£156.51 million	£119.31 million	$484.78 million	C$482.09 million
Beta	N/A	N/A	N/A	N/A	N/A
Average Volume	46,324	167,308	2,483,850	99,952	52,003
Sales & Book Value
Annual Revenue	C$246.08 million	£2.03 million	£17.03 million	N/A	C$7.30 million
Price / Sales	1.11	71.55	6.31	N/A	66.00
Cashflow	C$0.64 per share	GBX 4.96 per share	GBX 1.73 per share	N/A	C$3.90 per share
Price / Cash	6.18	42.31	8.57	N/A	6.09
Book Value	C$1.91 per share	GBX (3.80) per share	GBX 6.50 per share	N/A	C$4.82 per share
Price / Book	2.07	-0.55	0.02	N/A	4.93
Profitability
Net Income	N/A	N/A	N/A	N/A	N/A
EPS	C($0.36)	GBX (9.10)	GBX (0.60)	N/A	C($1.56)
Trailing P/E Ratio	N/A	N/A	N/A	0.00	N/A
Forward P/E Ratio	∞	∞	∞	N/A	∞
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	N/A	N/A	N/A
Return on Equity (ROE)	N/A	N/A	N/A	N/A	N/A
Return on Assets (ROA)	N/A	N/A	N/A	N/A	N/A
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	384.92%	375.32%	8.32%	N/A	1.72%
Current Ratio	2.69%	1.89%	2.21%	N/A	20.33%
Quick Ratio	2.61%	1.79%	2.01%	N/A	18.99%
Ownership Information
Institutional Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Insider Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Miscellaneous
Employees	1,737	72	136	186	109
Shares Outstanding	69.22 million	69.10 million	723.06 million	26.58 million	20.29 million
Next Earnings Date	6/2/2021 (Estimated)	N/A	N/A	6/15/2021 (Estimated)	5/6/2021 (Estimated)
Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable	N/A

Source	Headline
	Profound Medical to Participate in the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference finance.yahoo.com - April 14 at 6:46 PM
	Profound Medical (TSE:PRN) Trading 2% Higher americanbankingnews.com - April 3 at 12:14 AM
	Profound Medical Announces the Appointment of Cynthia Lavoie to its Board of Directors Toronto Stock Exchange:PRN compsmag.com - March 3 at 1:42 PM
	What's in a name for a vaccine campaign? Maybe the end of the pandemic medicalxpress.com - March 2 at 2:23 PM
	Victorian mental health royal commission final report finds system operates in crisis mode msn.com - March 1 at 6:41 PM
	Notre Dame nation mourns the death of former football star Louis Nix III msn.com - February 28 at 7:15 PM
	Woman's conviction in death of B.C. child may have been miscarriage of justice, review finds ca.news.yahoo.com - February 25 at 8:20 PM
	Maternal diet may enhance immune systems of premature infants, study shows news-medical.net - February 25 at 8:20 PM
	Study shows mother's diet may boost immune systems of premature infants medicalxpress.com - February 25 at 3:16 PM
	On the Front Lines of Diplomacy, but at the Back of the Vaccine Queue nytimes.com - February 24 at 2:54 PM
	Robert Jorvig, first Metropolitan Council head, dies at 99 msn.com - February 22 at 10:11 PM
	Myanmar: the EU needs to play the ASEAN card euobserver.com - February 22 at 1:47 AM
	‘Mr. Humble and Dr. Butcher’ Review: A Heart in the Right Place wsj.com - February 21 at 8:45 PM
	Full Transcript: San Diego State of the County Address 2021 msn.com - February 18 at 11:33 PM
	NBA All-Star 2021 to be held on March 7 in Atlanta, supporting HBCUs and COVID-19 equity efforts nba.com - February 18 at 1:28 PM
	U.K. coronavirus restrictions to include hotel quarantines, threats of fines and prison washingtonpost.com - February 11 at 12:24 AM
	This cutting-edge cloud-computing service is helping researchers track COVID's spread zdnet.com - February 10 at 7:56 AM
	Tire Kingdom Stores Treat More Hospital Workers moderntiredealer.com - February 9 at 6:53 AM
	Indian army organises Op Sadbhavana medical camp in Assam's Charaideo indiablooms.com - February 9 at 6:53 AM
	Tire Kingdom treats front-line workers at Pensacola hospitals tirebusiness.com - February 5 at 3:02 PM
	Global Medical Pressure Transducers Market 2020 Manufacturer Analysis, Technology Advancements, Industry Scope and Forecast to 2025 marketwatch.com - January 30 at 9:05 AM
	Medical Mobility Aid Device Market Research Report Includes Size, Capacity, Production, Revenue, Gross Margin, Forecast to 2026 marketwatch.com - January 20 at 6:29 AM
	U.S. Capitol Police officer dies after attack on Congress politico.com - January 8 at 12:39 PM
	Medical Software Market Size is Estimated to Accelerate at CAGR of 6.63% Industry Segmentation by Companies, Types and Application 2021 to 2025 marketwatch.com - January 8 at 7:39 AM
	A Look At The Fair Value Of Profound Medical Corp. (TSE:PRN) finance.yahoo.com - January 1 at 8:36 AM

Date	Company	Brokerage	Action
2/9/2021	Akumin	Clarus Securities	Reiterated Rating
10/21/2020	Akumin	National Bank Financial	Boost Price Target
8/17/2020	Akumin	Canaccord Genuity	Boost Price Target
7/27/2020	Oncimmune	FinnCap	Reiterated Rating
3/24/2021	Biodesix	Morgan Stanley	Boost Price Target
11/23/2020	Biodesix	William Blair	Initiated Coverage
11/23/2020	Biodesix	BTIG Research	Initiated Coverage
3/4/2021	Profound Medical	Leede Jones Gab	Reiterated Rating
2/26/2021	Profound Medical	Raymond James	Reiterated Rating
1/9/2019	Profound Medical	Echelon Wealth Partners	Reiterated Rating

(Data available from 4/21/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources